Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Co-Diagnostics is a US-based biotechnology company specializing in the development of innovative molecular diagnostic solutions. Through its patented CoPrimer™ technology, the company provides precise PCR tests for infectious disease and laboratory diagnostics to enhance accuracy in clinical testing.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Co-Diagnostics is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Co-Diagnostics last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -1.46 USD.
Co-Diagnostics has beaten analyst EPS estimates in 3 of its last 6 evaluated quarters (beat rate: 50%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.